Our Genevestigator analysis [140] also showed an increased CA9 level in samples of intraductal papillary mucinous adenoma, adenocarcinoma, and invasive carcinoma from patients with pancreatic cancer compared to normal pancreatic duct tissue (Figure 5). The gene discussed is CA9; the disease is invasive carcinoma.